Member Exclusive News

The week in industry: GBP £45 million awarded to tackle life threatening diseases

This week: Ned Sharpless to become acting chief of the FDA, the SMC does not approve of KYMIRAH® for patients with lymphoma on the NHS and collaboration announced to advance treatments for dermatology conditions.

Thumb untitled design
Mar 14, 2019

Please sign in or register for FREE

No comments yet.